Clal Insurance Enterprises Holdings Ltd - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Clal Insurance Enterprises Holdings Ltd ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,112
-43.2%
222,159
-58.0%
0.04%
-33.8%
Q2 2023$5,479
+12.0%
529,3880.0%0.06%
-11.0%
Q1 2023$4,892
+4.2%
529,3880.0%0.07%
+4.3%
Q4 2022$4,696
-99.9%
529,3880.0%0.07%
+16.7%
Q3 2022$4,405,000
+1.6%
529,3880.0%0.06%
+3.4%
Q2 2022$4,336,000
-6.0%
529,3880.0%0.06%
+18.4%
Q1 2022$4,611,000
-8.4%
529,3880.0%0.05%
-9.3%
Q4 2021$5,034,000
-43.5%
529,3880.0%0.05%
-47.1%
Q3 2021$8,904,000
+10.1%
529,3880.0%0.10%
+10.9%
Q2 2021$8,084,000
-21.6%
529,3880.0%0.09%
-22.7%
Q1 2021$10,312,000
+15.7%
529,3880.0%0.12%
-1.7%
Q4 2020$8,913,000
-12.7%
529,3880.0%0.12%
-29.7%
Q3 2020$10,212,000
-26.1%
529,3880.0%0.17%
-37.2%
Q2 2020$13,828,000
+46.4%
529,3880.0%0.27%
+16.1%
Q1 2020$9,444,000
-98.2%
529,388
+2896.6%
0.24%
-58.5%
Q4 2019$529,388,000
+4096.5%
17,666
-96.7%
0.57%
+85.0%
Q3 2019$12,615,000
-36.6%
529,388
-4.4%
0.31%
-33.0%
Q2 2019$19,903,000
-2.9%
553,778
-0.2%
0.46%
-8.8%
Q1 2019$20,501,000
+19.2%
554,974
+39.0%
0.50%
+12.3%
Q4 2018$17,192,000
+17.4%
399,262
+28.8%
0.45%
+14.9%
Q3 2018$14,641,000
-5.1%
310,0000.0%0.39%
-3.0%
Q2 2018$15,426,000
+9.5%
310,000
+9.3%
0.40%
+7.2%
Q1 2018$14,087,000
+8386.1%
283,500
+6255.1%
0.37%
+9250.0%
Q4 2017$166,0004,4610.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders